Valuation (69%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 16.14 | 30.12 |
PEG Ratio (TTM) | -4.20 | 0.40 |
P/S Ratio (TTM) | 1.59 | 5.82 |
P/B Ratio (TTM) | 1.89 | 16.47 |
P/FCF Ratio (TTM) | 9.26 | 26.03 |
Price to 5YR AVG Earnings Ratio | 36.14 | 88.59 |
Price to 5YR AVG FCF Ratio | 37.82 | 45.05 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 6.63% | 10.52% |
ROE (TTM) | 11.45% | 43.52% |
Net Profit Margin (TTM) | 10.01% | 16.41% |
ROIC 5YR AVG | 6.00% | 19.14% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 1.17% | -26.19% | 5.10% |
Revenue | -0.84% | -5.86% | -1.98% |
Net Income | -1.88% | -25.49% | 3.29% |
Cash Flow | 284.68% | -10.30% | 22.78% |
Health (79%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.78 | 0.68 |
Quick Ratio (TTM) | 1.72 | 0.61 |
D/E Ratio (TTM) | 0.30 | 2.05 |
Interest Coverage (TTM) | 11.70 | 29.32 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 3.20 | 6.04 |
LTL to 5YR AVG FCF | 2.52 | 3.21 |
Shares Outstanding Growth 5YR AVG | -1.78% | -0.66% |